Wen‐Long Guan
About
In The Last Decade
Wen‐Long Guan
26 papers receiving 807 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 400
- Pulmonary and Respiratory Medicine 309
- Molecular Biology 226
- Surgery 204
- Cancer Research 189
Countries citing papers authored by Wen‐Long Guan
This map shows the geographic impact of Wen‐Long Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Long Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Long Guan more than expected).
Fields of papers citing papers by Wen‐Long Guan
This network shows the impact of papers produced by Wen‐Long Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Long Guan. The network helps show where Wen‐Long Guan may publish in the future.
Co-authorship network of co-authors of Wen‐Long Guan
This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Long Guan. A scholar is included among the top collaborators of Wen‐Long Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Long Guan. Wen‐Long Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 7 | |
| 5 | 9 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study breakdown → | 77 |
| 9 | Gastric cancer treatment: recent progress and future perspectives breakdown → | 423 |
| 10 | 5 | |
| 11 | 35 | |
| 12 | 11 | |
| 13 | Research on antibody changes and nucleic acid clearance in COVID-19 patients treated with convalescent plasma. | 2 |
| 14 | 12 | |
| 15 | 26 | |
| 16 | 3 | |
| 17 | 2 | |
| 18 | 6 | |
| 19 | 31 | |
| 20 | 48 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.